Enterprise Operational Lead - SCRI/SCDI (Secondment - 12-Months)

WHY PATIENTS NEED YOU This 12-month, 80% secondment provides a development opportunity for an experienced clinical operations leader to take enterprise-level accountability for the Pfizer -SCRI/SCDI operational partnership under the Accelero model. The role is positioned within the Global Study Management (GSM) group in Global Site and Study Operations (GSSO), works closely with Strategic Partnerships, and serves as the primary Pfizer operational interface for SCRI and Sarah Cannon Development Innovations (SCDI) across the Accelero portfolio. WHAT YOU WILL ACHIEVE The role operates above individual-study execution. It enables portfolio visibility, consistent application of the approved operating model, cross-functional coordination, risk-based oversight, and timely enterprise escalation without duplicating accountabilities held by Study Teams, Vendor Leads, CRO project teams, Quality, or sites. The successful colleague will gain broad exposure to strategic partnership management, enterprise governance, vendor oversight, operating-model evolution, and senior internal and external stakeholders while contributing to the operational maturity and scalability of a strategically important oncology partnership. HOW YOU WILL ACHIEVE IT Enterprise portfolio oversight:Maintain an integrated view across Accelero studies, including portfolio-level dependencies, recurring risks, trends, and issues requiring cross-study coordination or enterprise action. Single operational interface:Act as